This is a demo store. No orders will be fulfilled.

Mirikizumab (anti-IL-23) - Primary antibody, specific to IL23A, >95%, high purity, Human IgG4SP, INHIBITOR of Interleukin-23 inhibitor, INHIBITOR of Interleukin-23 inhibitor

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • Host species: Human
  • Reactive species: Cynomolgus monkey,Human,Rabbit
  • Isotype: Human IgG4SP
  • Conjugation: Unconjugated
In stock
Item Number
Ab175599
Grouped product items
SKU Size
Availability
Price Qty
Ab175599-100μg
100μg
10
$59.90
Ab175599-1mg
1mg
4
$279.90
Ab175599-5mg
5mg
1
$739.90
Ab175599-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,189.90

Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product Name Mirikizumab (anti-IL-23) - Primary antibody, specific to IL23A, >95%, high purity, Human IgG4SP, INHIBITOR of Interleukin-23 inhibitor
Synonyms IL 23 A antibody | IL 23 antibody | IL 23 subunit alpha antibody | IL 23A antibody | IL 23p19 antibody | IL-23 subunit alpha antibody | IL-23-A antibody | IL-23p19 antibody | IL12B antibody | IL23 antibody | Il23a antibody | IL23A_HUMAN antibody | IL23P19
Specifications & Purity Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Host species Human
Specificity IL23A
Conjugation Unconjugated
Grade Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action Type INHIBITOR
Mechanism of action INHIBITOR of Interleukin-23 inhibitor
Product Description

Mirikizumab (anti-IL-23) is a humanized IgG4 monoclonal antibody targets the p19 subunit of interleukin 23. Mirikizumab (anti-IL-23) can be used for the research of ulcerative colitis.

Product Properties

Isotype Human IgG4SP
Light Chain Type kappa
SDS-PAGE 26.4 kDa (Light Chain) & 51.8 kDa (Heavy Chain), under reducing conditions; 181.9 kDa, under non-reducing conditions.
Purification Method Protein A purified
Purity >95%
Shape Liquid
Concentration See COA
Storage Temp Store at -80°C,Avoid repeated freezing and thawing
Shipped In Ice chest + Ice pads
Stability And Storage Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
CAS 1884201-71-1

Associated Targets(Human)

IL23A Tclin Interleukin-23 subunit alpha (0 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)

Images

Mirikizumab (anti-IL-23) (Ab175599) - ELISA
Immobilized Mirikizumab (anti-IL-23) (Ab175599) at 2.0 μg/mL can bind rhIL-23p19-N-His IL-12p40 with the EC₅₀0 of 29.41 ng/mL.

Mirikizumab (anti-IL-23) (Ab175599) - SEC
The purity of Mirikizumab (anti-IL-23) (Ab175599) is more than 95% verified by HPLC.

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot Number Certificate Type Date Item
ZJ24F0404284 Certificate of Analysis Apr 10, 2024 Ab175599
ZJ24F0404283 Certificate of Analysis Apr 10, 2024 Ab175599
ZJ24F0404282 Certificate of Analysis Apr 10, 2024 Ab175599

Alternative Products

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.